In vivo imaging of trypanosome-brain interactions and development of a rapid screening test for drugs against CNS stage trypanosomiasis.

HUMAN AFRICAN TRYPANOSOMIASIS (HAT) MANIFESTS IN TWO STAGES OF DISEASE: firstly, haemolymphatic, and secondly, an encephalitic phase involving the central nervous system (CNS). New drugs to treat the second-stage disease are urgently needed, yet testing of novel drug candidates is a slow process bec...

Full description

Saved in:
Bibliographic Details
Main Authors: Elmarie Myburgh, Jonathan A Coles, Ryan Ritchie, Peter G E Kennedy, Alex P McLatchie, Jean Rodgers, Martin C Taylor, Michael P Barrett, James M Brewer, Jeremy C Mottram
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0002384&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850119129909952512
author Elmarie Myburgh
Jonathan A Coles
Ryan Ritchie
Peter G E Kennedy
Alex P McLatchie
Jean Rodgers
Martin C Taylor
Michael P Barrett
James M Brewer
Jeremy C Mottram
author_facet Elmarie Myburgh
Jonathan A Coles
Ryan Ritchie
Peter G E Kennedy
Alex P McLatchie
Jean Rodgers
Martin C Taylor
Michael P Barrett
James M Brewer
Jeremy C Mottram
author_sort Elmarie Myburgh
collection DOAJ
description HUMAN AFRICAN TRYPANOSOMIASIS (HAT) MANIFESTS IN TWO STAGES OF DISEASE: firstly, haemolymphatic, and secondly, an encephalitic phase involving the central nervous system (CNS). New drugs to treat the second-stage disease are urgently needed, yet testing of novel drug candidates is a slow process because the established animal model relies on detecting parasitemia in the blood as late as 180 days after treatment. To expedite compound screening, we have modified the GVR35 strain of Trypanosoma brucei brucei to express luciferase, and have monitored parasite distribution in infected mice following treatment with trypanocidal compounds using serial, non-invasive, bioluminescence imaging. Parasites were detected in the brains of infected mice following treatment with diminazene, a drug which cures stage 1 but not stage 2 disease. Intravital multi-photon microscopy revealed that trypanosomes enter the brain meninges as early as day 5 post-infection but can be killed by diminazene, whereas those that cross the blood-brain barrier and enter the parenchyma by day 21 survived treatment and later caused bloodstream recrudescence. In contrast, all bioluminescent parasites were permanently eliminated by treatment with melarsoprol and DB829, compounds known to cure stage 2 disease. We show that this use of imaging reduces by two thirds the time taken to assess drug efficacy and provides a dual-modal imaging platform for monitoring trypanosome infection in different areas of the brain.
format Article
id doaj-art-d8f63ebc485e4ac5958df2b230b0fd99
institution OA Journals
issn 1935-2727
1935-2735
language English
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj-art-d8f63ebc485e4ac5958df2b230b0fd992025-08-20T02:35:43ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352013-01-0178e238410.1371/journal.pntd.0002384In vivo imaging of trypanosome-brain interactions and development of a rapid screening test for drugs against CNS stage trypanosomiasis.Elmarie MyburghJonathan A ColesRyan RitchiePeter G E KennedyAlex P McLatchieJean RodgersMartin C TaylorMichael P BarrettJames M BrewerJeremy C MottramHUMAN AFRICAN TRYPANOSOMIASIS (HAT) MANIFESTS IN TWO STAGES OF DISEASE: firstly, haemolymphatic, and secondly, an encephalitic phase involving the central nervous system (CNS). New drugs to treat the second-stage disease are urgently needed, yet testing of novel drug candidates is a slow process because the established animal model relies on detecting parasitemia in the blood as late as 180 days after treatment. To expedite compound screening, we have modified the GVR35 strain of Trypanosoma brucei brucei to express luciferase, and have monitored parasite distribution in infected mice following treatment with trypanocidal compounds using serial, non-invasive, bioluminescence imaging. Parasites were detected in the brains of infected mice following treatment with diminazene, a drug which cures stage 1 but not stage 2 disease. Intravital multi-photon microscopy revealed that trypanosomes enter the brain meninges as early as day 5 post-infection but can be killed by diminazene, whereas those that cross the blood-brain barrier and enter the parenchyma by day 21 survived treatment and later caused bloodstream recrudescence. In contrast, all bioluminescent parasites were permanently eliminated by treatment with melarsoprol and DB829, compounds known to cure stage 2 disease. We show that this use of imaging reduces by two thirds the time taken to assess drug efficacy and provides a dual-modal imaging platform for monitoring trypanosome infection in different areas of the brain.https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0002384&type=printable
spellingShingle Elmarie Myburgh
Jonathan A Coles
Ryan Ritchie
Peter G E Kennedy
Alex P McLatchie
Jean Rodgers
Martin C Taylor
Michael P Barrett
James M Brewer
Jeremy C Mottram
In vivo imaging of trypanosome-brain interactions and development of a rapid screening test for drugs against CNS stage trypanosomiasis.
PLoS Neglected Tropical Diseases
title In vivo imaging of trypanosome-brain interactions and development of a rapid screening test for drugs against CNS stage trypanosomiasis.
title_full In vivo imaging of trypanosome-brain interactions and development of a rapid screening test for drugs against CNS stage trypanosomiasis.
title_fullStr In vivo imaging of trypanosome-brain interactions and development of a rapid screening test for drugs against CNS stage trypanosomiasis.
title_full_unstemmed In vivo imaging of trypanosome-brain interactions and development of a rapid screening test for drugs against CNS stage trypanosomiasis.
title_short In vivo imaging of trypanosome-brain interactions and development of a rapid screening test for drugs against CNS stage trypanosomiasis.
title_sort in vivo imaging of trypanosome brain interactions and development of a rapid screening test for drugs against cns stage trypanosomiasis
url https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0002384&type=printable
work_keys_str_mv AT elmariemyburgh invivoimagingoftrypanosomebraininteractionsanddevelopmentofarapidscreeningtestfordrugsagainstcnsstagetrypanosomiasis
AT jonathanacoles invivoimagingoftrypanosomebraininteractionsanddevelopmentofarapidscreeningtestfordrugsagainstcnsstagetrypanosomiasis
AT ryanritchie invivoimagingoftrypanosomebraininteractionsanddevelopmentofarapidscreeningtestfordrugsagainstcnsstagetrypanosomiasis
AT petergekennedy invivoimagingoftrypanosomebraininteractionsanddevelopmentofarapidscreeningtestfordrugsagainstcnsstagetrypanosomiasis
AT alexpmclatchie invivoimagingoftrypanosomebraininteractionsanddevelopmentofarapidscreeningtestfordrugsagainstcnsstagetrypanosomiasis
AT jeanrodgers invivoimagingoftrypanosomebraininteractionsanddevelopmentofarapidscreeningtestfordrugsagainstcnsstagetrypanosomiasis
AT martinctaylor invivoimagingoftrypanosomebraininteractionsanddevelopmentofarapidscreeningtestfordrugsagainstcnsstagetrypanosomiasis
AT michaelpbarrett invivoimagingoftrypanosomebraininteractionsanddevelopmentofarapidscreeningtestfordrugsagainstcnsstagetrypanosomiasis
AT jamesmbrewer invivoimagingoftrypanosomebraininteractionsanddevelopmentofarapidscreeningtestfordrugsagainstcnsstagetrypanosomiasis
AT jeremycmottram invivoimagingoftrypanosomebraininteractionsanddevelopmentofarapidscreeningtestfordrugsagainstcnsstagetrypanosomiasis